Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trialNalinie Joharatnam‐Hogan, R. Steele, Sam Rowley et al.|The Lancet. Gastroenterology & hepatology|2019Cited by 64
A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI™), in patients with advanced solid tumoursEdwina N. Scott, Johann S. de Bono, Anne Thomas et al.|Cancer Chemotherapy and Pharmacology|2009Cited by 34
A phase I study of intravenous TZT-1027 administered on day 1 and day 8 of a three-weekly cycle in combination with carboplatin given on day 1 alone in patients with advanced solid tumoursAlastair Greystoke, William P. Steward, Sarah P. Blagden et al.|Annals of Oncology|2006Cited by 24
Frequency of S492R Mutations in the Epidermal Growth Factor Receptor: Analysis of Plasma Dna from Metastatic Colorectal Cancer Patients Treated with Panitumumab or Cetuximab MonotherapyKathryn J. Newhall, R. Sidhu, Timothy Price et al.|Annals of Oncology|2014Cited by 23
Title Page / ContentsS.W.J. Lamberts, David Nott, Anna Maria Baldelli et al.|Chemotherapy|2001Cited by 0